Dauntless Investment Group, LLC - Sep 30, 2025 SCHEDULE 13G/A Report for OKYO Pharma Ltd Common (OKYO)

Filing Manager: Dauntless Investment Group, LLC
Reporting Manager: Dauntless Investment Group, LLC
Security: OKYO Pharma Ltd Common
Symbol: OKYO
Shares outstanding: 38.4M shares
Disclosed Ownership: 2.42M shares
Ownership: 6.3%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 12:50 PM
Date of event: Sep 30, 2025
Previous filing: Aug 5, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Dauntless Investment Group, LLC	6.3%	2.42M	0	0	/s/Matthew Okkerse	CFO